Vantas® (histrelin implant) is a medicine prescribed to treat the symptoms of advanced prostate cancer that has spread to other areas of the body. It is available as an implant that is surgically inserted just under the skin of the upper arm. This product is specifically designed to gradually release a certain amount of medicine over a 12-month period.
Vantas works by decreasing testosterone levels in the body. This can help slow down the growth of testosterone-sensitive prostate cancer cells.
Although it is generally well tolerated, this drug is not suitable for everyone. Before using Vantas, make sure your healthcare provider has up-to-date information on your medical history and a list of your current medications. In particular, make sure to let your healthcare provider know if you have osteoporosis, diabetes, or heart disease.
(Click Vantas for more information on using this medication. Topics discussed in this article include potential side effects, available strengths, and safety issues to be aware of while using it.)
Vantas Web site. Available at: http://www.vantasimplant.com/default.aspx. Accessed June 30, 2011.
Lexi-Interact [computer program]. Lexi-Comp, Inc.; June 29, 2011.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed June 29, 2011.
Histrelin. Drug Facts and Comparisons. Drug Facts and Comparisons 4.0 [online]. 2011. Available from Wolters Kluwer Health, Inc. Accessed June 29, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click